Patrick Schnell

Clinical Experience With Crizotinib in Patients With Advanced <i>ALK</i>-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases

Daniel B. Costa, Alice T. Shaw, Sai‐Hong Ignatius Ou et al. · Journal of Clinical Oncology · 2015 · 605 citations · Full text

Medicine, Oncology, Pharmacology +14

Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

Simon Travis, Dan Schnell, Piotr Krzeski et al. · Gastroenterology · 2013 · 446 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3)

Sunil Verma, Cynthia Huang Bartlett, Patrick Schnell et al. · The Oncologist · 2016 · 246 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18

Richard S. Finn, John Crown, Johannes Ettl et al. · Breast Cancer Research · 2016 · 185 citations · Full text

Medicine, Oncology, Pharmacology +17

Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer

Véronique Dièras, Hope S. Rugo, Patrick Schnell et al. · JNCI Journal of the National Cancer Institute · 2018 · 99 citations · Full text

Pharmacy, Oncology, Pharmacology +17